Skip to main content
MedPathMedPath Home
Clinical Trials/DRKS00026171
DRKS00026171
Recruiting
Not Applicable

Prospective observational study to investigate the long-term course of MR-guided percutaneous tumor ablation of primary or secondary liver or kidney tumors

niversitätsklinikum Tübingen0 sites300 target enrollmentAugust 23, 2021
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsC22C64Malignant neoplasm of liver and intrahepatic bile ductsMalignant neoplasm of kidney, except renal pelvis

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
C22
Sponsor
niversitätsklinikum Tübingen
Enrollment
300
Status
Recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 23, 2021
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
niversitätsklinikum Tübingen

Eligibility Criteria

Inclusion Criteria

  • •Patients who have clinically indicated tumor ablation for primary or secondary liver or kidney tumors.
  • •\- The indication for percutaneous tumor ablation takes place in an interdisciplinarytumor conference.
  • •\- Completion of the age of 18 and the patient's legal capacity to give consent.
  • •\- Concomitant diseases or adjuvant chemotherapy or previous therapy using transarterial chemotherapy or other ablation procedures do not constitute exclusion criteria for participation in the study.

Exclusion Criteria

  • •\- Missing or incomplete declaration of consent from the patient.
  • •\- Minor patients.
  • •\- Pregnant / breastfeeding women.
  • •\- Patients incapable of giving consent.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Study to investigate the feasibility of layer to layer suturing for artificial ulcers after endoscopic resection of gastrointestinal tumorsGastrointestinal tumors
JPRN-UMIN000046388Keio University30
Completed
Not Applicable
Prospective observational study to investigate the predictors of trastuzumab induced cardiac toxicity in breast cancer patients with perioperative chemotherapybreast cancer
JPRN-UMIN000016962Graduate School of Medicine Kyoto University50
Not yet recruiting
Not Applicable
Prospective observational study to investigate the relationships between pharmacokinetics and therapeutic efficacy and adverse effect of Janus kinase inhibitor in rheumatoid arthritis.Rheumatoid arthritis
JPRN-UMIN000048381Department of Hospital Pharmacy, Hamamatsu University School of Medicine100
Not yet recruiting
Not Applicable
Prospective observational study to investigate the health benefits of the smartphone application hiPanyaSleep problems (to be distinguished from sleep disorders as defined by the inclusion and exclusion criteria of this study)
DRKS00034323Medigital GmbH98
Completed
Not Applicable
Prospective observational study to investigate the predictive factors on the efficacy of molecular targeting therapy for unresectable advanced hepatocellular carcinoma.hepatocellular carcinoma
JPRN-UMIN000010000Japanese Red Cross Liver Study Group150